Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
Journal of Medicinal Chemistry - United States
doi 10.1021/acs.jmedchem.5b00760
Full Text
Open PDFAbstract
Available in full text
Date
June 3, 2015
Authors
Publisher
American Chemical Society (ACS)